Recurrent genetic defects in classical Hodgkin lymphoma cell lines

References

• Schmitz R, Stanelle J, Hansmann ML, et al. Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma. Annu Rev Pathol. 2009;4:151–174.
   PubMed Web of Science ®Google Scholar
• Schouten HC, Sanger WG, Duggan M, et al. Chromosomal abnormalities in Hodgkin’s disease. Blood. 1989;73:2149–2154.
   PubMed Web of Science ®Google Scholar
• Falzetti D, Crescenzi B, Matteuci C, et al. Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin’s disease. Haematologica. 1999;84:298–305.
   PubMed Web of Science ®Google Scholar
• Pedersen RK, Sørensen AG, Pedersen NT, et al. Chromosome aberrations in adult Hodgkin disease in a Danish population-based study. Cancer Genet Cytogenet. 1999;110:128–132.
   PubMedGoogle Scholar
• Hartmann S, Martin-Subero JI, Gesk S, et al. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin’s lymphoma by array-based comparative genomic hybridization. Haematologica. 2008;93:1318–1326.
   PubMed Web of Science ®Google Scholar
• Tiacci E, Döring C, Brune V, et al. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma. Blood. 2012;120:4609–4620.
   PubMed Web of Science ®Google Scholar
• Feys T, Poppe B, De Preter K, et al. A detailed inventory of DNA copy number alterations in four commonly used Hodgkin’s lymphoma cell lines. Haematologica. 2007;92:913–920.
   PubMed Web of Science ®Google Scholar
• Giefing M, Arnemann J, Martin-Subero JI, et al. Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines. Br J Haematol. 2008;142:916–924.
   PubMed Web of Science ®Google Scholar
• Liu Y, Abdul Razak FR, Terpstra M, et al. The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing. Leukemia. 2014;28:2248–2251.
   PubMed Web of Science ®Google Scholar
• Reichel J, Chadburn A, Rubinstein PG, et al. Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells. Blood. 2015;125:1061–1072.
   PubMed Web of Science ®Google Scholar
• Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754–1760.
   PubMed Web of Science ®Google Scholar
• McKenna A, Hanna M, Banks E, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–1303.
   PubMed Web of Science ®Google Scholar
• Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164.
   PubMed Web of Science ®Google Scholar
• Robinson JT, Thorvaldsdóttir H, Winckler W. Integrative genomics viewer. Nat Biotechnol. 2011;29:24–26.
   PubMed Web of Science ®Google Scholar
• Li H, Handsaker B, Wysoker A, et al. The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25:2078–2079.
   PubMed Web of Science ®Google Scholar
• Koboldt DC, Zhang Q, Larson DE, et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22:568–576.
   PubMed Web of Science ®Google Scholar
• Venkatraman ES, Olshen AB. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics. 2007;23:657–663.
   PubMed Web of Science ®Google Scholar
• Krzywinski M, Schein J, Birol I, et al. Circos: an information aesthetic for comparative genomics. Genome Res. 2009;19:1639–1645.
   PubMed Web of Science ®Google Scholar
• Martín-Subero JI, Gesk S, Harder L, et al. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood. 2002;99:1474–1477.
   PubMed Web of Science ®Google Scholar
• Joos S, Granzow M, Holtgreve-Grez H, et al. Hodgkin’s lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2. Int J Cancer. 2003;103:489–495.
   PubMed Web of Science ®Google Scholar
• Green MR, Monti S, Rodig SJ, et al. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood. 2010;116:3268–3277.
   PubMed Web of Science ®Google Scholar
• Joos S, Küpper M, Ohl S, et al. Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res. 2000;60:549–552.
   PubMed Web of Science ®Google Scholar
• Van Roosbroeck K, Cox L, Tousseyn T, et al. JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma. Blood. 2011;117:4056–4064.
   PubMed Web of Science ®Google Scholar
• Otto C, Giefing M, Massow A, et al. Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma. Br J Haematol. 2012;157:702–708.
   PubMed Web of Science ®Google Scholar
• Küpper M, Joos S, von Bonin F, et al. MDM2 gene amplification and lack of p53 point mutations in Hodgkin and Reed-Sternberg cells: results from single-cell polymerase chain reaction and molecular cytogenetic studies. Br J Haematol. 2001;112:768–775.
   PubMed Web of Science ®Google Scholar
• Green MR, Rodig S, Juszczynski P, et al. Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy. Clin Cancer Res. 2012;18:1611–1618.
   PubMed Web of Science ®Google Scholar
• Barth TF, Martin-Subero JI, Joos S, et al. Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma. Blood. 2003;101:3681–3686.
   PubMed Web of Science ®Google Scholar
• Enciso-Mora V, Broderick P, Ma Y, et al. A genome-wide association study of Hodgkin’s lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat Genet. 2010;42:1126–1130.
   PubMed Web of Science ®Google Scholar
• Giefing M, Winoto-Morbach S, Sosna J, et al. Hodgkin-reed-sternberg cells in classical Hodgkin lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacity. PLoS One. 2013;8:e84928.
   PubMed Web of Science ®Google Scholar
• Overbeck BM, Martin-Subero JI, Ammerpohl O, et al. ETS1 encoding a transcription factor involved in B-cell differentiation is recurrently deleted and down-regulated in classical Hodgkin’s lymphoma. Haematologica. 2012;97:1612–1614.
   PubMed Web of Science ®Google Scholar
• Björkholm M, Sjöberg J, Nygell UA, et al. Development of Hodgkin lymphoma in homozygotic triplets with constitutional deletion in MKL1. Blood. 2013;121:4807.
   PubMed Web of Science ®Google Scholar
• Szymanowska N, Klapper W, Gesk S, et al. BCL2 and BCL3 are recurrent translocation partners of the IGH locus. Cancer Genet Cytogenet. 2008;186:110–114.
   PubMedGoogle Scholar
• Steidl C, Shah SP, Woolcock BW, et al. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature. 2011;471:377–381.
   PubMed Web of Science ®Google Scholar
• Martín-Subero JI, Klapper W, Sotnikova A, et al. Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. Cancer Res. 2006;66:10332–10338.
   PubMed Web of Science ®Google Scholar
• Schmidt A, Schmitz R, Giefing M, et al. Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma. Genes Chromosomes Cancer. 2010;49:803.
   PubMed Web of Science ®Google Scholar
• Müschen M, Re D, Bräuninger A, et al. Somatic mutations of the CD95 gene in Hodgkin and Reed-Sternberg cells. Cancer Res. 2000;60:5640–5643.
   PubMed Web of Science ®Google Scholar
• Maggio E, Van Den Berg A, de Jong D, et al. Low frequency of FAS mutations in Reed-Sternberg cells of Hodgkin’s lymphoma. Am J Pathol. 2003;162:29–35.
   PubMed Web of Science ®Google Scholar
• Krem MM, Salipante SJ, Horwitz MS. Mutations in a gene encoding a midbody protein in binucleated Reed-Sternberg cells of Hodgkin lymphoma. Cell Cycle. 2010;9:670–675.
   PubMed Web of Science ®Google Scholar
• Lake A, Shield L, Cordano P, et al. Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases. Int J Cancer. 2009;125:1334–1342.
   PubMed Web of Science ®Google Scholar
• Liu X, Yu H, Yang W, et al. Mutations of NFKBIA in biopsy specimens from Hodgkin lymphoma. Cancer Genet Cytogenet. 2010;197:152–157.
   PubMedGoogle Scholar
• Cabannes E, Khan G, Aillet F, et al. Mutations in the IkBa gene in Hodgkin’s disease suggest a tumour suppressor role for IkappaBalpha. Oncogene. 1999;18:3063–3070.
   PubMed Web of Science ®Google Scholar
• Emmerich F, Theurich S, Hummel M, et al. Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells. J Pathol. 2003;201:413–420.
   PubMed Web of Science ®Google Scholar
• Gunawardana J, Chan FC, Telenius A, et al. Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma. Nat Genet. 2014;46:329–335.
   PubMed Web of Science ®Google Scholar
• Weniger MA, Melzner I, Menz CK, et al. Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation. Oncogene. 2006;25:2679–2684.
   PubMed Web of Science ®Google Scholar
• Mottok A, Renné C, Seifert M, et al. Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities. Blood. 2009;114:4503–4506.
   PubMed Web of Science ®Google Scholar
• Chen W, Chen Y, Kamel O, et al. p53 mutations in Hodgkin’s disease. Lab Invest. 1996;75:519–527.
   PubMed Web of Science ®Google Scholar
• Feuerborn A, Möritz C, Von Bonin F, et al. Dysfunctional p53 deletion mutants in cell lines derived from Hodgkin’s lymphoma. Leuk Lymphoma. 2006;47:1932–1940.
   PubMed Web of Science ®Google Scholar
• Nomoto J, Hiramoto N, Kato M, et al. Deletion of the TNFAIP3/A20 gene detected by FICTION analysis in classical Hodgkin lymphoma. BMC Cancer. 2012;12:457.
   PubMed Web of Science ®Google Scholar
• Schmitz R, Hansmann M, Bohle V, et al. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med. 2009;206:981–989.
   PubMed Web of Science ®Google Scholar
• Küppers R. NPAT mutations in Hodgkin lymphoma. Blood. 2011;118:484–485.
   PubMed Web of Science ®Google Scholar
• Saarinen S, Aavikko M, Aittomäki K, et al. Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma. Blood. 2011;118:493–498.
   PubMed Web of Science ®Google Scholar
• Rui L, Emre NC, Kruhlak MJ, et al. Cooperative epigenetic modulation by cancer amplicon genes. Cancer Cell. 2010;18:590–605.
   PubMed Web of Science ®Google Scholar
• MacLeod RA, Spitzer D, Bar-Am I, et al. Karyotypic dissection of Hodgkin’s disease cell lines reveals ectopic subtelomeres and ribosomal DNA at sites of multiple jumping translocations and genomic amplification. Leukemia. 2000;14:1803–1814.
   PubMed Web of Science ®Google Scholar
• Re D, Zander T, Diehl V, et al. Genetic instability in Hodgkin’s lymphoma. Ann Oncol. 2002;13:19–22.
   PubMed Web of Science ®Google Scholar
• Barretina J, Caponigro G, Stransky N, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483:603–307.
   PubMed Web of Science ®Google Scholar
• Küppers R. New insights in the biology of Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program. 2012;1:328–334.
   Google Scholar
• Labeit S, Ottenheijm CA, Granzier H. Nebulin, a major player in muscle health and disease. FASEB J. 2011;25:822–829.
   PubMed Web of Science ®Google Scholar
• Tang TK. Centriole biogenesis in multiciliated cells. Nat Cell Biol. 2013;15:1400–1402.
   PubMed Web of Science ®Google Scholar
• Hibino S, Kato K, Kudoh S, et al. Tenascin suppresses CD3-mediated T cell activation. Biochem Biophys Res Commun. 1998;250:119–124.
   PubMed Web of Science ®Google Scholar
• Isakson P, Holland P, Simonsen A. The role of ALFY in selective autophagy. Cell Death Differ. 2013;20:12–20.
   PubMed Web of Science ®Google Scholar
• Lawrence MS, Stojanov P, Polak P, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499:214–218.
   PubMed Web of Science ®Google Scholar
• Drexler HG. Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines. Leuk Lymphoma. 1993;9:1–25.
   PubMed Web of Science ®Google Scholar